Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 21;16(1):79.
doi: 10.1186/s13065-022-00869-z.

Smart stability indicating spectrophotometric methods for determination of modafinil: the promising treatment for post-covid neurological syndrome

Affiliations

Smart stability indicating spectrophotometric methods for determination of modafinil: the promising treatment for post-covid neurological syndrome

Soha G Elsheikh et al. BMC Chem. .

Abstract

Modafinil (MDF) is one of the neurostimulants with a potential effect in the COVID-19 ICU ventilated patients and post-COVID neurological syndrome treatment. Four rapid, simple and cost-effective stability indicating spectrophotometric methods were used for estimation of MDF in the presence of its acidic degradation product, namely; ratio difference (RD), first derivative of the ratio spectra (1DD), mean centering (MCR) and ratio subtraction method (RS). These methods were validated according to ICH guidelines and all methods revealed a good linearity in concentration range of (5-30 µg/mL) in addition to a good accuracy and precision with mean percentage recovery of 99.97 ± 0.305 for (RD), 100.10 ± 0.560 for (1DD), 100.02 ± 0.483 for (MCR) & 99.18 ± 1.145 for (RS) method. Specificity of the proposed methods was assessed and MDF was determined in the presence of up to 80% of its acidic degradation product for RD, 1DD, MCR and RS methods. The proposed methods were successfully applied for the determination of MDF in bulk powder and its tablet dosage form with mean percentage recovery of 100.33 ± 0.915 for (RD), 100.62 ± 0.985 for (1DD), 99.70 ± 0.379 for (MCR) and 100.21 ± 0.313 for (RS) method. The results obtained were statistically compared with those of official HPLC method and showed no significant difference with relevance accuracy and precision.

Keywords: Derivative ratio; Mean centering; Modafinil; Ratio difference; Ratio subtraction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Chemical structure of Modafinil
Fig. 2
Fig. 2
Zero order absorption spectra of (10 µg/mL) modafinil (–) and (70 µg/mL) of its acidic degradation (-—-) in methanol
Fig. 3
Fig. 3
Ratio spectra of modafinil 5-30 µg/mL(–) and 50 µg/mL of its acidic degradation product (-—-) using 70 µg/mL of degradation as a divisor in methanol
Fig. 4
Fig. 4
First derivative of ratio spectra of 5-30 µg/mL modafinil (–) and 50 µg/mL of degradation product () using 70 µg/mL of degradation as a divisor at (241.8 nm) in methanol
Fig. 5
Fig. 5
Mean centering of ratio spectra of MDF 5-30 µg/mL using the spectrum of 70 µg/mL of degradation as a divisor at 226 nm in methanol
Fig. 6
Fig. 6
A Ratio spectra of laboratory prepared mixtures of modafinil and its degradation product using 70 µg/mL of its degradation product as a divisor. B The obtained ratio spectra after subtraction of the constant. C The obtained spectra of modafinil after multiplication by the divisor. D Second derivative of the obtained spectra of the laboratory prepared mixtures

Similar articles

Cited by

References

    1. BP. British Pharmacopoeia, The Stationary Office, London, 2013.
    1. Duchêne A, Perier M, Zhao Y, Liu X, Thomasson J, Chauveau F, Piérard C, Lagarde D, Picoli C, Jeanson T. Impact of astroglial connexins on modafinil pharmacological properties. Sleep. 2016;39(6):1283–1292. doi: 10.5665/sleep.5854. - DOI - PMC - PubMed
    1. Kaleita T, Wellisch D, Graham C, Steh B, Nghiemphu P, Ford J, Lai A, Peak S, Cloughesy T. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. J Clin Oncol. 2006;24(18 suppl):1503–1503. doi: 10.1200/jco.2006.24.18_suppl.1503. - DOI
    1. Roy D, Song J, Awad N, Zamudio P. Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19. BMJ Case Rep. 2021;14(3):e239781. doi: 10.1136/bcr-2020-239781. - DOI - PMC - PubMed
    1. Amer M, Bawazeer M, Butt AS, Dahhan TI, Kseibi E, Jamil MG. Modafinil for Wakefulness in the critical care units: a literature review and case series including COVID-19 patients at a tertiary care saudi hospital. medRxiv. 2021 doi: 10.1101/2021.02.11.21250832. - DOI

LinkOut - more resources